Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Isn’t this down another 50% since September report?

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Jan 28, 2022 3:13pm

159 Views

Post# 34372697

RE:Isn’t this down another 50% since September report?

On Sept 30, 2021 it was at $11.19
On Dec 31, 2021 it was at $11.56
So ... it should appear as a slight increase in value on the next financials - if we still held at Dec 31.

No idea of we kept it or sold it off.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season